[PL2]Glutathione supersulfide controls viral infection and immunometabolism in lung disease
○Takaaki Akaike1(1. Department of Redox Molecular Medicine, Tohoku University Graduate School of Medicine (Japan))
検索条件
フリーワード：
開催年：
2021〜2026
すべてのイベントから検索します。検索結果は最大１万件まで表示されます。
〜
検索条件
| フリーワード： | |
|---|---|
| 開催年： | 2021〜2026 |
すべてのイベントから検索します。検索結果は最大１万件まで表示されます。
〜
検索結果(737)
[S5-1]Modulating immunogenicity and reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization
○Yasuo Yoshioka1,2,3,4,5(1. Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan), 3. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 4. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 5. The Research Foundation for Microbial Diseases of Osaka University (Japan))
[S5-3]Development of an Intranasal Therapeutic Vaccine for Cervical Cancer Leveraging the Mucosal Homing Pathway
○Rika Nakahashi1(1. Chiba University Hospital, Human Mucosal Vaccinology (Japan))
[S5-4]Antibody-guided structure-based immunogens for vaccine-difficult pathogens like HIV-1
○Peter D. Kwong1(1. ADARC, Columbia University (USA))
[PL3]Deciphering Highly Pathogenic Avian Influenza in Mammalian Hosts
○Yoshihiro Kawaoka1(1. UTOPIA (Japan))
[S3-1]Structural Vaccinology Driving Next-Generation Influenza Pandemic Countermeasures
○Masaru Kanekiyo1(1. Vaccine Research Center, NIAID, National Institutes of Health (USA))
[S3-2]Understanding healthy aging in centenarians by defining molecular profiles of virus-specific CD8+ T cells & innate immunity
Tejas Menon1, Aira Cabug1, Thi HO Nguyen1, Louise Rowntree1, Jennifer Habel1, Shihan Li1, Isabelle Foo1, Theo Karapanagiotidis2, Suellen Nicholson2, Priyanka Chaurasia3, Dene Littler3, Stephanie Gras3,4, Jamie Rossjohn3,5, Jane Crowe6, Katie Flanagan7, Fabio Luciani8, Jan Schroeder1, Lukasz Kedzierski1, Carolien van de Sandt1, ○Katherine Kedzierska1(1. University of Melbourne and Doherty Institute (Australia), 2. VIDRL, Doherty Institute (Australia), 3. Monash University (Australia), 4. La Trobe University (Australia), 5. Cardiff University School of Medicine (UK), 6. Deepdene Surgery (Australia), 7. University of Tasmania (Australia), 8. The Kirby Institute, UNSW Sydney (Australia))
[S3-3]Discrimination of Self and Neoself Antigens by T Cells in Immune Homeostasis
○Hisashi Arase1,2(1. Department of Immunochemistry, Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. Laboratory of Immunochemistry, Immunology Frontier Research Center, The University of Osaka (Japan))
[S3-4]mRNA Stability Governs Immune Homeostasis Through Innate Lymphoid Cells
○Takashi Ebihara1(1. Department of Microbiology and Immunology, Akita University Graduate School of Medicine (Japan))
[S3-5]The Contribution of Aging to the Development of Immune-Related Adverse Events Associated with Cancer Immunotherapy
○Hirotake Tsukamoto1(1. Center for Cancer Immunotherapy and Immunobiology, Kyoto University (Japan))
[S2-1]Host cell remodelling by the malaria parasite is coordinated by the AP2-HCR DNA-binding protein
Amit K. Subudhi1, Sara Mfarrej1, Rahul Salunke1, Reem Abu-Shamma1, Di Liu1, Maya Aaych2, David P.J. Ferguson3, Sabrina Absalon4, ○Arnab Pain1(1. BioMed Division, King Abdullah University of Science and Technology (KAUST) (Saudi Arabia), 2. KAUST Corelab, King Abdullah University of Science and Technology (KAUST) (Saudi Arabia), 3. Nuffield Department of Clinical Laboratory Sciences and John Radcliffe Hospital, University of Oxford (UK), 4. Department of Pharmacology and Toxicology, Indiana University (USA))
[S2-2]Domain Analysis of CST1 Reveals a Disulfide-Linked Scaffold That Maintains Cyst Wall Protein Organization and Rigidity in Toxoplasma gondii
○Tadakimi Tomita1, Louis M Weiss1(1. Albert Einstein College of Medicine (USA))
[S2-3]First whole genomic analysis of a dominant Cryptosporidium parvum sub-genotype in Japan isolated from a calf with severe diarrhea
○Makoto Matsubayashi1(1. Osaka Metropolitan University (Japan))
[S2-4]Mechanisms of ridge formation and cytoadhesion to endothelial cells of Babesia bovis–infected erythrocytes
Hassan Hakimi1,2, Atefeh Fathi1, Junya Yamagishi3, Miako Sakaguchi4, Shin-ichiro Kawazu1, ○Masahito Asada1(1. National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine (Japan), 2. Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University (USA), 3. International Institute for Zoonosis Control, Hokkaido University (Japan), 4. Institute of Tropical Medicine (NEKKEN), Nagasaki University (Japan))
[S2-5]Unveiling the Tick Microbiome via 16S/18S rRNA Amplicon Sequencing: Symbionts and the Discovery of Keystone Species
○Ryo Nakao1, Yurie Taya2(1. Faculty of Veterinary Medicine, Hokkaido University (Japan), 2. International Institute for Zoonosis Control, Hokkaido University (Japan))
[P066]From Protein Trafficking to Cytoadhesion: Establishing a Screening Platform for Plasmodium knowlesi Virulence
○Huai Chuang1,2, Yuka Appelboom1,2,3, Yuko Katakai4, Satoru Kawai5,6, Miako Sakaguchi7, Osamu Kaneko1,2(1. Dept. Protozoology, Institute of Tropical Medicine(Nekken), Nagasaki Univ. (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki Univ. (Japan), 3. Master’s program of Biomedical Sciences, Leiden Univ. Medical Center, Leiden Univ. (Netherlands), 4. The Corporation for Production and Research of Laboratory Primates (Japan), 5. Dept. Tropical Medicine and Parasitology, Dokkyo Medical Univ. (Japan), 6. Amami Laboratory of Injurious Animals Institute of Medical Science, The Univ. Tokyo (Japan), 7. Central Laboratory, Institute of Tropical Medicine(Nekken), Nagasaki Univ. (Japan))
[P067]Early Cutaneous Invasion and Active Immunomodulation by Strongyloides venezuelensis infective larvae: A Histological and Transcriptomic Investigation
○Safira Rosalina1, Ryusei Tanaka1, Mio Kokubo-Tanaka1, Junichi Miyagawa1, Eiji Nagayasu1, Haruhiko Maruyama1(1. Department of Parasitology, University of Miyazaki (Japan))
[P068]Andrographolide as a promising alternative treatment for Giardia infection
○TAPAS HALDAR1, Sandipan Ganguly(1. Postdoctoral Fellow, Institute of Tropical Medicine, Nagasaki University (Japan))
[P069]Analysis of the molecular basis of host specificity of Babesia bovis using an artificial evolutionary approach
○Khesara Sastrin Prasita Negara1,2,3, Kyoko Hayashida1,2, Tatsuki Sugi1,2, Masahito Asada4, Junya Yamagishi1,2(1. Collabed, IIZC, Hokkaido University (Japan), 2. GSID, Hokkaido University (Japan), 3. LPM, FM, Universitas Sebelas Maret (Indonesia), 4. NRCPD, Obihiro University of Agriculture and Veterinary Medicine (Japan))
[P070]Development of transient transfection system in Theileria orientalis
○Kota Komatsu1, Kyoko Hayashida2, Junya Yamagishi2, Shin-ichiro Kawazu1, Masahito Asada1(1. National research center for protozoan diseases (Japan), 2. International institute for zoonosis control (Japan))
[P071]Characterization of GRA7-dependent host responses in chronic Toxoplasma gondii infection
○Rie Kubota1, Shu Nakamura1, Tatsuki Sugi2, Yoshifumi Nishikawa1(1. National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine (Japan), 2. International Institute for Zoonosis Control, Hokkaido University (Japan))
[P072]Are pyrethrum spray catches and CDC light traps comparable for indoor Anopheles surveillance? Evidence from western Kenya.
○Robert Ouko Muga1,2, Kyoko Futami1,2, Toshihiko Sunahara1,2, George O. Sonye3, Peter Lutiali4, Noboru Minakawa2(1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. 2.Nekken, Nagasaki University (Japan), 3. 3.Ability to solve by Knowledge (ASK) (Kenya), 4. 4.NUITM/KEMRI (Kenya))
[P073]Exploring vertical transmission of Plasmodium falciparum at the maternal-fetal interface in the Democratic Republic of the Congo.
○Nestor KALALA TSHITUKA1,2, Yoshinori Okina1, Evariste Tshibangu Kabamba1,4, Nadine Kayiba Kalenda2, Yu Nakagama1, Shun Nakagama1, Dieudonné Mumba Ngoyi3, Natsuko Kaku1, Ghislain Disashi Tumba4, Yasutoshi Kido1(1. Osaka Metropolitan University (Japan), 2. Department of Public Health, Faculty of Medicine – Pharmacy and Public Health, University of Mbujimayi, Mbujimayi. (Democratic Republic of the Congo), 3. Department of Parasitology, National Institute of Biomedical Research (INRB), Kinshasa. (Democratic Republic of the Congo), 4. Department of Internal Medecine, Faculty of Medicine, Pharmacy and Public Health, University of Mbujimayi, Mbujimayi. (Democratic Republic of the Congo))
[P074]Characterization of Kilobase-Scale Genomic Deletion by CRISPR/Cas3 System in Toxoplasma gondii
○Tatsuki Sugi1, Naoko Kawai1, Kyoko Hayashida1, Junya Yamagishi1, Yoshifumi Nishikawa2(1. International Institute for Zoonosis Control, Hokkaido University (Japan), 2. National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine (Japan))
[P075 (O06)]The Toxoplasma microneme protein MIC11 is essential for PLP1-mediated egress from host cells
○Yuta Tachibana1,2, Masahiro Yamamoto1,2(1. Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. WPI Immunology Frontier Research Center, The University of Osaka (Japan))
[P076]Perturbation of human bone marrow mesenchymal stem cell differentiation by Plasmodium falciparum
○Jason Wirya1,2, Akiko Baba2, Ben Yeddy-Abel Chintama2, Tapas Haldar2, Yukiko Miyazaki2, Viviane Keiko dos Santos Kawata-Matsuura3, Osamu Kaneko2, Shinya Miyazaki2(1. School of Tropical Medicine and Global Health, Nagasaki University (Japan), 2. Department of Protozoology, Institute of Tropical Medicine, Nagasaki University (Japan), 3. Department of Vaccine Informatics, Institute of Tropical Medicine, Nagasaki University (Japan))
[P079]Composite scoring system for capturing cardiac involvement in chronic Chagas disease
○Yu Nakagama1, Susana Peña2, Mercedes Menjívar2, Ricardo Menjívar2, Ana Maricela Mejía3, Karla Marina Alas3, Carmen Elena Arias3, Katherine-Sofia Candray-Medina1,4, Sachie Nakagama1, Yuko Nitahara1, Shun Nakagama1, Natsuko Kaku1, Yoko Onizuka5, Junko Nakajima-Shimada5, Rosa María Guerrero3, Yasutoshi Kido1(1. Graduate School of Medicine, Osaka Metropolitan University (Japan), 2. National Rosales Hospital (El Salvador), 3. Gerencia Científica en Apoyo a la Educación (El Salvador), 4. El Salvador National Institute of Health (El Salvador), 5. Graduate School of Health Sciences, Gunma University (Japan))
[P080]Amprenavir as a potential therapeutic candidate for HIV–Leishmaniasis co-infections, acting through Leishmania donovani Topoisomerase I inhibition and oxidative stress-mediated programmed cell death
○Sachidananda Behera1,2,4, Amit Roy3,4, Parool Gupta1,2, Vahab Ali1,4(1. Department of Biochemistry, ICMR-Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna (India), 2. Department of Pharmacy, AISECT University, Hazaribagh, Jharkhand-825313, India (India), 3. Department of Biotechnology, Savitribai Phule Pune University, Pune-411007, Maharastra (India), 4. Department of Biotechnology, National Institute of Pharmaceutical Education and Research, NIPER, Hajipur (India))
[S4-1]Virulence and Host Adaptation in the Mycobacterium tuberculosis Complex
○Stephen Gordon1,2(1. University College Dublin (Ireland), 2. Hokkaido University (Japan))
[S4-2]Rapid and Comprehensive Optimization of Complex Natural Products via In Situ Build-Up Library Construction
○Satoshi Ichikawa1(1. Faculty of Pharmaceutical Sciences, Hokkaido University (Japan))
[S4-3]Legionella alters the host epitranscriptome
○Elizabeth L Hartland1(1. Hudson Institute of Medical Research (Australia))
[S4-4]Exploring novel antibiotic targets in Staphylococcus aureus
○Wonsik Lee1, JuOae Chang1, Ji-Hoon Kim1(1. Sungkyunkwan University (Korea))
[S4-5]Legionella co-opts host SNARE through reversible ubiquitination to optimize replicative niche formation
○Tomoe Kitao1(1. International Institute for Zoonosis Control, Hokkaido University (Japan))
[S1-1]A microglia-specific antiviral defense targeting ESCRT-dependent viruses
○Sébastien Nisole1(1. INRS - Centre Armand-Frappier Santé Biotechnologie (Canada))
[S1-2]Exploring the role of host translational compatibility in positive-sense RNA tropism
○Tomokazu Tamura1,2(1. Faculty of Medical Sciences, Kyushu University (Japan), 2. Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University (Japan))
[S1-3]Infectious Disease Pathology Approaches to Emerging Tick-Borne Viral Infections: Establishing Causality and Elucidating Pathogenesis
○Tadaki Suzuki1,2(1. Department of Infectious Disease Pathology, NIID, JIHS (Japan), 2. Department of Infectious Disease Pathobiology, Graduate School of Medicine, Chiba University (Japan))
[S1-4]Identification and Characterization of Ensitrelvir as an Oral Antiviral for SARS-CoV-2: Preclinical Efficacy and Broad Anti-Coronavirus Potential
○Michihito Sasaki1,2, Akihiko Sato1,2,3, Hirofumi Sawa1,2, Yasuko Orba1,2(1. International Institute for Zoonosis Control, Hokkaido University (Japan), 2. Institute for Vaccine Research and Development, Hokkaido University (Japan), 3. Laboratory for Drug Discovery & Disease Research, Shionogi & Co., Ltd. (Japan))
[S1-5]Integrated genomic and epigenomic analysis for therapeutic target discovery in HTLV-1-associated diseases
○Makoto Yamagishi1(1. Graduate School of Frontier Sciences, The University of Tokyo (Japan))
[P096]Multimerization of the Mumps Virus HN Protein Potently Enhances Neutralizing Antibody Induction
○Shura Yarimizu1, Takuya Hemmi1,2,3, Nozomi Abe1, Yuma Sato1, Takao Hashiguchi1(1. Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyo to University (Japan), 2. Host Protection Dynamics Team, Center for Infectious Disease Education and Research, The University of Osaka (Japan), 3. Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan (Japan))
[P097]Clinically translatable intradermal delivery of a live attenuated Leishmania vaccine preserves efficacy
○FARZANEH VALANEZHAD1,2,3, Jalal Alshaweesh1,2, Shara Bakytbek1,2,3, Alireza Valanezhad4, Kawsar Talaat5, Greg Matlashewski6, Sreenivas Gannavaram7, Hira Nakhasi7, Abhay Satoskar8, Shinjiro Hamano1,2,3(1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki, Japan (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki, Japan (Japan), 4. Department of Dental and Biomedical Materials Science, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan (Japan), 5. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. (USA), 6. Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada (Canada), 7. Division of Emerging and Transfusion-Transmitted Diseases, CBER, FDA, Silver Spring, MD, 20993 US (USA), 8. Department of Pathology, The Ohio State University, Columbus, Ohio, US (USA))
[P098]AI guided humoral and cellular antigen engineering for broad betacoronavirus mRNA vaccine design
○Kaidre Bendjama1,2, Alexandru Odainic2, Matheus Ferraz2, Ioannis Vardaxis2, Marius Gheorghe2, Sebastian Kapell1,2, Pierre Machart3, Raman Siarheyeu3, Yuki Tanaka4(1. University of Nagasaki (Japan), 2. NEC Oncoimmunity (Norway), 3. NEC Laboratories Europe (Germany), 4. NEC Corporation (Japan))
[P099]Serotype-Specific Neutralization and Antibody-Dependent Enhancement in a Dengue Community Cluster Cohort in Bandung, Indonesia (2005–2009)
○Malihe Naderi1, Chrisan Bimo Prayuda2,3, Jean Claude Balingit1,4, Silvita Fitri Riswari2,5, Gita Widya Pradini2,5, Siti Rasnawati Mony2, Dionisius Denis6, Diana S. Hansen7, Tedjo Sasmono8, Mya Myat Ngwe Tun1,9,10,11, Kouichi Morita1,9, Bachti Alisjahbana2,5,12(1. Department of Tropical Viral Vaccine Development, Institute of Tropical Medicine (Japan), 2. Research Center for Care and Control of Infectious Disease (RC3ID), Universitas Padjadjaran, Indonesia (Indonesia), 3. Faculty of Medicine, Universitas Islam Bandung, Indonesia. (Indonesia), 4. Department of Clinical Microbiology, Umeå universitet, Sweden (Sweden), 5. Faculty of Medicine, Universitas Padjadjaran, Indonesia. (Indonesia), 6. Exeins Health Initiative (EHI), Jakarta, Indonesia (Indonesia), 7. Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, Victoria, Australia (Australia), 8. Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Indonesia (Indonesia), 9. Department of Virology, Institute of Tropical Medicine, Nagasaki University. (Japan), 10. Center for Vaccines and Therapeutic Antibodies for Emerging Infectious Diseases, Shimane University (Japan), 11. DEJIMA Infectious Disease Research Alliance, Nagasaki University (Japan), 12. Department of Internal Medicine, Hasan Sadikin General Hospital, Indonesia. (Indonesia))
[P100]T-Cell Immunogenicity of AI-Predicted Malaria Vaccine Elements Assessed by IFN-γ Enzyme-Linked Immunospot Assay
○Shara Bakytbek1,2,3, Agnieszka Gromadka4, Wataru Kagaya3,5, Huai Chuang3,6, Yarob Ibraheem1,2,3, Farzaneh Valanezhad1,2,3, Ayako Hyuga1,2,3, Marius Gheorghe4, Daiki Miura7, Alexandru Odainic4, Shin-Ichi Inoue2,3,8, Shusaku Mizukami3,9, Satoshi Kaneko3,5, Kazuhide Onoguchi7, Sebastian Kapell3,4,10, Kaïdre Bendjama3,4, Osamu Kaneko2,3,6, Shinjiro Hamano1,2,3(1. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), The Joint Usage/Research Center on Tropical Disease, Nagasaki University, Nagasaki (Japan), 2. Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki (Japan), 3. The Vaccine Research and Development Center, DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University, Nagasaki (Japan), 4. NEC Oncoimmunity AS, Oslo (Norway), 5. Department of Eco-epidemiology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 6. Department of Protozoology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 7. AI Drug Development Division, NEC Corporation, Tokyo (Japan), 8. Department of Molecular Microbiology and Immunology, Division of Immunology, Nagasaki University, Nagasaki (Japan), 9. Department of Immune Regulations, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan), 10. Department of Vaccine Informatics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki (Japan))
[P101]Development of Paired αβ and β-Chain Transformer Models for TCR–Epitope Binding Prediction
○Micheal Teron Pillay1, Shara Bakytbek2, Anton Kratz1, Kaidre Bendjama1,3, Sebastian Kapell1,3(1. Nagasaki University, Institute of Tropical Medicine, Department of Vaccine Informatics (Japan), 2. Nagasaki University, Institute of Tropical Medicine, Department of Parasitology (Japan), 3. NEC Oncoimmunity AS, Oslo (Norway))
[P081]Functional Analysis of the Effector Functions of Vδ2 γδ T Cells and NK Cells against HTLV-1-Infected T cells.
○Ifeanyi Theodora Ndubuisi1, Lilian Chepgetich Koech1, Satoshi Kaneko1, Yoshimasa Tanaka2(1. Institute of Tropical Medicine, Nagasaki University (Japan), 2. Center for Medical Innovation, Nagasaki University (Japan))
[P083]Characterization of Innate Immune Responses and Severity Biomarkers in Neonatal Sepsis in India
○Yadya M Chawla1, M Jeeva Sankar2, Murali-Krishna Kaja1,3, Anmol Chadele1(1. International Centre for Genetic Engineering and Biotechnology (India), 2. All India Institute of Medical Sciences (India), 3. Emory University (USA))
[P084]Molecular Mechanism of Specific HIV-2 Capsid Recognition by host innate immune sensor NONO
○Yoji Mori1, Nanao Fujitani1, Manel Nicolas2, Kimiko Kuroki1, Katsumi Maenaka1,3,4,5(1. Faculty of Pharmaceutical Sciences, Hokkaido University (Japan), 2. Institut Curie (France), 3. Inter. Inst. Zoonosis Control, Hokkaido Univ. (Japan), 4. Inst. Vaccine Res. & Devel., Hokkaido Univ. (Japan), 5. Facul. Pharm. Sci., Kyushu Univ. (Japan))
[P085]Plasma Tryptophan Pathway Metabolites and TMAO in Long COVID with Neurological Manifestations
○Dinara Turebekova1, Irina Kadyrova1, Zhaniya Dauletkaliyeva2, Dmitriy Solyanov1, Shynar Muratbekova3(1. The Scientific Research Laboratory, Institute of Life Sciences, Karaganda Medical University, Karaganda, Kazakhstan (Kazakhstan), 2. School of Public Health, Karaganda Medical University, Karaganda, Kazakhstan (Kazakhstan), 3. Department of Neurology, Psychiatry and Rehabilitation, Karaganda Medical University, Karaganda, Kazakhstan (Kazakhstan))
[P086]A Plasmodium vivax mRNA-LNP Vaccine Candidate Drives Robust B Cell Differentiation and Multifunctional Cytokine Profiles in Human Tonsil Organoids
○Thitinan Kitisin1, Thananya Jinato2, Nilnetre Mahathanaruk3, Jetsumon Sattabongkot2, Lisa E. Wagar4,5,6(1. Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand (Thailand), 2. Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol, University, Bangkok, Thailand (Thailand), 3. Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (Thailand), 4. Department of Physiology & Biophysics, University of California, Irvine, Irvine, CA, USA (USA), 5. Institute for Immunology, University of California, Irvine, Irvine, CA, USA (USA), 6. Center for Virus Research, University of California, Irvine, Irvine, CA, USA (USA))
[P087 (O07)]Adaptive Immune Receptor Repertoires (AIRRs) Link Individual Stimulus Responses with Pooled Genetic Variance
○Steven Matthew Heaton1, Shohei Kojima1,2, Miki Kojima1, Tomoko Kasahara1, Hiromi Sano1, Fumie Yokoyama1, Anselmo Jiro Kamada1,3, Rie Koide1, Asami Fujii Gelinas1, Takashi Watanabe1, Takaho Endo1, Yoshinari Ando1, Kokoro Ozaki1, Yasuhiro Murakawa1, Chikashi Terao1, Nicholas Fredrick Parrish1,4(1. RIKEN Center for Integrative Medical Sciences (Japan), 2. Keio University (Japan), 3. University of Oxford Department of Biology (UK), 4. Duke University Department of Surgery (USA))
737 件中 ( 1 - 50 )
- 1
- ...